AbbVie Inc is a leading American biopharmaceutical company, established in 2013 from a spin-off of Abbott Laboratories. The company specializes in the research, development, and commercialization of advanced therapies in immunology, oncology, virology, and neuroscience. With a robust pipeline of innovative treatments, AbbVie is committed to addressing some of the world's most challenging health issues and is recognized for its blockbuster immunology drug, Humira. AbbVie continues to strengthen its portfolio through strategic acquisitions and collaborations, positioning itself as a formidable player in the global biopharmaceutical landscape.
Click "Analyze" to generate stock analysis
ABBV Price Trend and Signals
ABBV Option Volumes & Open Interests (aggregated)
ABBV Put Call Ratios and IV (aggregated)
ABBV Financials
2025-10-14Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-14Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-14Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-14Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.